Cargando…

Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis

The objective of this study was to assess the relationship between short‐term and long‐term treatment effects measured by the American College of Rheumatology (ACR) 50 responses and to assess the feasibility of predicting 6‐month efficacy from short‐term data. A rheumatoid arthritis (RA) database wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yehong, Zhu, Rui, Xiao, Jim, Davis, John C., Mandema, Jaap W., Jin, Jin Y., Tang, Meina T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064749/ https://www.ncbi.nlm.nih.gov/pubmed/26517752 http://dx.doi.org/10.1002/jcph.668

Ejemplares similares

Prevention vs treatment of rheumatoid arthritis
por: Klareskog, Lars, et al.
Publicado: (2023)

Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
por: Hughes, Derralynn A, et al.
Publicado: (2023)

Non-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical study
por: Crilly, Michael A, et al.
Publicado: (2011)

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
por: Laroche-Clary, A, et al.
Publicado: (2015)

Long‐term clinical course of idiopathic pulmonary haemosiderosis with rheumatoid arthritis
por: Sugimoto, Shunsuke, et al.
Publicado: (2016)

The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness
por: Hessl, David, et al.
Publicado: (2022)

Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
por: El Ghali, Amer, et al.
Publicado: (2023)

Therapeutic benefits of proning to improve pulmonary gas exchange in severe respiratory failure: focus on fundamentals of physiology
por: Berg, Ronan M. G., et al.
Publicado: (2021)

PROMIS Fatigue short forms are reliable and valid in adults with rheumatoid arthritis
por: Bingham III, Clifton O., et al.
Publicado: (2019)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
por: Ortiz, Alberto, et al.
Publicado: (2016)

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
por: Cohen, Stanley, et al.
Publicado: (2019)

Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis
por: van Vollenhoven, Ronald, et al.
Publicado: (2019)

Age, Cognitive Factors, and Acceptance of Living with the Disease in Rheumatoid Arthritis: The Short-Term Perspective
por: Pankowski, Daniel, et al.
Publicado: (2022)

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
por: Gualberto, A, et al.
Publicado: (2011)

Statistical Primer on Biosimilar Clinical Development
por: Isakov, Leah, et al.
Publicado: (2016)

Benefits of Exercise in Rheumatoid Arthritis
por: Cooney, Jennifer K., et al.
Publicado: (2011)

Statins Do Not Influence Long-Term Rituximab Clinical Efficiency in Rheumatoid Arthritis Patients
por: Mazilu, Diana, et al.
Publicado: (2014)

Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases
por: Nikiphorou, Elena, et al.
Publicado: (2016)

Medium‐Term Clinical Results of High‐Flexion Knee Prostheses in Patients with Rheumatoid Arthritis
por: Xu, Xiao‐hui, et al.
Publicado: (2021)

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
por: Feun, L G, et al.
Publicado: (2012)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Khan, Abdul, et al.
Publicado: (2011)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca, Giuseppe, et al.
Publicado: (2013)

The Long-Term Effects of Treating Rheumatoid Arthritis
por: Scott, D. L., et al.
Publicado: (1983)

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis
por: Bergstra, Sytske Anne, et al.
Publicado: (2017)

Prognostic factors for the short-term mortality of patients with rheumatoid arthritis admitted to intensive care units
por: Fujiwara, Toshifumi, et al.
Publicado: (2020)

Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression
por: Tardella, Marika, et al.
Publicado: (2021)

Conversion to total hip arthroplasty in posttraumatic arthritis: short-term clinical outcomes
por: Taheriazam, Afshin, et al.
Publicado: (2019)

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
por: Moore, Thomas J, et al.
Publicado: (2020)

Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest
por: Barnes, Kay B., et al.
Publicado: (2019)

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
por: Kory, Pierre, et al.
Publicado: (2021)

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
por: Li, Hanbin, et al.
Publicado: (2019)

Reliability of Ultrasound for the Detection of Rheumatoid Arthritis
por: Hassan, Rabia, et al.
Publicado: (2019)

Utility of Baseline Transcriptomic Analysis of Rheumatoid Arthritis Synovium as an Indicator for Long-Term Clinical Outcomes
por: Anaparti, Vidyanand, et al.
Publicado: (2022)

Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice
por: Huss, Viking, et al.
Publicado: (2021)

Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017)

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection
por: Kunkel, M., et al.
Publicado: (2023)

Long-term efficacy and safety of biologics in rheumatoid arthritis
por: Montecucco, Carlomaurizio
Publicado: (2012)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis
por: Bergstedt, Dylan T., et al.
Publicado: (2022)

Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
por: Kawka, Michal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2trbmbeu8d4m1o7imdvp4hf8f0